ESSENCE Study: Efficacy and Safety of SD-101 Cream in Patients With Epidermolysis Bullosa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02384460
Recruitment Status : Completed
First Posted : March 10, 2015
Last Update Posted : August 4, 2017
Amicus Therapeutics, Inc.
Information provided by (Responsible Party):
Scioderm, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2017
  Actual Study Completion Date : July 2017